Publications by authors named "Pierre Peeters"

Claim this Profile
P
Proof of pharmacology of Org 48775-0, a p38 MAP kinase inhibitor, in healthy volunteers.
Matthijs Moerland, Andrea J Kales, Karen Broekhuizen, Ulla Nässander, Rob Nelissen, Pierre A M Peeters

Br J Clin Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of the Dual Orexin Receptor Antagonist Daridorexant in Japanese and Caucasian Subjects.
Clemens Muehlan, Rob Zuiker, Pierre Peeters, Racheal Rowles, Jasper Dingemanse

J Clin Psychopharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Dermal Absorption of Aluminum from a Representative Antiperspirant Formulation Using a Al Microtracer Approach.
Rianne de Ligt, Esther van Duijn, Dimitri Grossouw, Sieto Bosgra, Jacobus Burggraaf, Pierre A M Peeters

Clin Transl Sci· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological interactions between brivaracetam and ethanol in healthy males.
Annelieke C Kruithof, Shikiko Watanabe, Pierre Am Peeters, Marieke L de Kam, Rob Gja Zuiker

J Psychopharmacol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of food on the high clearance drug asenapine after sublingual administration to healthy male volunteers.
Peter Dogterom, Rik de Greef, Pierre A M Peeters

Eur J Clin Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects.
Pieter-Jan De Kam, Peter Grobara, Marita Prohn, Floris Höppener, Cornelis Kluft, Pierre Peeters

Int J Clin Pharmacol Ther· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters.
Pieter-Jan de Kam, Rachid El Galta, Annelieke C Kruithof, Hein Fennema, Marie-José van Lierop, Pierre Peeters

Int J Clin Pharmacol Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of sugammadex on QT/QTc interval prolongation when combined with QTc-prolonging sevoflurane or propofol anaesthesia.
Pieter-Jan de Kam, Peter Grobara, Justin Dennie, Guy Cammu, Steven Ramael, Pierre A M Peeters

Clin Drug Investig· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early stage development of the glycine-1 re-uptake inhibitor SCH 900435: central nervous system effects compared with placebo in healthy men.
Marieke Liem-Moolenaar, Pierre Peeters, Ingrid M C Kamerling, Chris Hogg, Graham Holder

Br J Clin Pharmacol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic profile of nomegestrol acetate and 17β-estradiol after multiple and single dosing in healthy women.
Mireille G F Gerrits, Peter G Schnabel, Teun M Post, Pierre A M Peeters

Contraception· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine Safety, Tolerability, and Pharmacokinetics After Single and Multiple Doses in Healthy Volunteers.
Peter Dogterom, Cees Timmer, Rik de Greef, Edwin Spaans, Dick de Vries, Pierre Peeters

Clin Pharmacol Drug Dev· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
Pieter-Jan de Kam, Jacqueline van Kuijk, Jean Smeets, Torben Thomsen, Pierre Peeters

Int J Clin Pharmacol Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproate reduces the glucuronidation of asenapine without affecting asenapine plasma concentrations.
Mireille G F Gerrits, Rik de Greef, Peter Dogterom, Pierre A M Peeters

J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.
Deepak Cyril D'Souza, Nagendra Singh, Jacqueline Elander, Michelle Carbuto, Brian Pittman, Pierre Peeters

Neuropsychopharmacology· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flucloxacillin and diclofenac do not cause recurrence of neuromuscular blockade after reversal with sugammadex.
Pieter-Jan de Kam, Michiel W van den Heuvel, Peter Grobara, Alex Zwiers, Jean-Luc Jadoul, Pierre A M Peeters

Clin Drug Investig· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine pharmacokinetics in hepatic and renal impairment.
Pierre Peeters, Howard Bockbrader, Edwin Spaans, Peter Dogterom, Kenneth Lasseter

Clin Pharmacokinet· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
Johannes G Ramaekers, Silke Conen, Pieter Jan de Kam, Sabine Braat, Pierre Peeters

Psychopharmacology (Berl)· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sugammadex is cleared rapidly and primarily unchanged via renal excretion.
Pierre Peeters, Paul Passier, Jean Smeets, Alex Zwiers, Marcel de Zwart

Biopharm Drug Dispos· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study.
Pierre A M Peeters, Michiel W van den Heuvel, Emiel van Heumen, Paul C C M Passier, Jean M W Smeets

Clin Drug Investig· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
Pieter-Jan de Kam, Jacqueline van Kuijk, Marita Prohn, Torben Thomsen, Pierre Peeters

Clin Drug Investig· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects.
Mireille Gerrits, Rik de Greef, Pierre Peeters

Biopharm Drug Dispos· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis